Delving Into Participation Trends in Renal Cell Carcinoma Studies - Trial NCT06093568
Access comprehensive clinical trial information for NCT06093568 through Pure Global AI's free database. This phase not specified trial is sponsored by Power Life Sciences Inc. and is currently Not yet recruiting. The study focuses on Renal Cell Carcinoma. Target enrollment is 500 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Power Life Sciences Inc.
Timeline & Enrollment
N/A
Nov 01, 2024
Nov 01, 2026
Primary Outcome
Number of patients who decide to participate in a renal cell carcinoma clinical study,Rate of patients who remain in renal cell carcinoma clinical trial to trial completion
Summary
The study seeks to delve into the firsthand experiences of patients diagnosed with renal cell
 carcinoma who partake in a separate clinical study featuring a specific medical intervention.
 The primary emphasis will be on meticulously tracking the rates of trial completion and
 withdrawal among these individuals.
 
 By joining this clinical trial, individuals have the unique opportunity to contribute to the
 betterment of future renal cell carcinoma patients and play an active role in advancing
 clinical research.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06093568
Non-Device Trial